Rigorous and groundbreaking science is at the core of what we do at GMP

Our R&D activities are focused on applying excellent science to discover and develop potential new medicines utilizing common and rare cannabinoids as the main API. We approach each new indication-based therapeutic formula to become best-in-class.


1. Cardiac Amyloidosis

2. Tourette Syndrome

3. Acquired Neuromyotonia

4. Complex Regional Pain Syndrome

5. Cerebral Palsy

6. Trigeminal Neuralgia

7. Tardive Dyskinesia


Autism Spectrum Disorder

Phase 3

Cardiac Amyloidosis

Phase 2

Pain, Sleep & Mood

Starting Soon
More Details

Product Portfolio

Patented Intellectual Property

Our R&D lab, led by our experienced product development
team has perfected several different proprietary
nano-suspended formulas that will be first-to-market in the
Cannabis landscape. From fine-mist sublingual sprays to
nebulizer formulas to IV drips, our team is ensuring
ground-breaking formulas and perfect dosing methods for
an array of medicinal relief.

Learn More

GMP Allience

Strategic Partnerships

GMP Discovery has affiliations with some of
the top institutions in the following countries:

Canada, Israel, Germany, Korea, Mexico, Netherlands, UAE, India, & Japan